Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseases

References

• Wang Y, Le WD. Autophagy and ubiquitin-proteasome system. Adv Exp Med Biol. 2019;1206:527–550.
   PubMed Web of Science ®Google Scholar
• Feng Y, He D, Yao Z, et al. The machinery of macroautophagy. Cell Res. 2014 Jan;24(1):24–41.
   PubMed Web of Science ®Google Scholar
• Morishita H, Mizushima N. Diverse cellular roles of autophagy. Annu Rev Cell Dev Biol. 2019 Oct 6;35:453–475.
   PubMed Web of Science ®Google Scholar
• Mizushima N. A brief history of autophagy from cell biology to physiology and disease. Nat Cell Biol. 2018 May;20(5):521–527.
   PubMed Web of Science ®Google Scholar
• Luo L, Qin ZH. Autophagy, aging, and longevity. Adv Exp Med Biol. 2019;1206:509–525.
   PubMed Web of Science ®Google Scholar
• Saha S, Panigrahi DP, Patil S, et al. Autophagy in health and disease: a comprehensive review. Biomed Pharmacother. 2018;104:485–495.
   PubMed Web of Science ®Google Scholar
• Roskoski R Jr. A historical overview of protein kinases and their targeted small molecule inhibitors. Pharmacol Res. 2015 Oct;100:1–23.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang X. Kinases involved in both autophagy and mitosis. Int J Mol Sci. 2017 Aug 31;18(9). pii: E1884.
   Web of Science ®Google Scholar
• Zachari M, Ganley IG. The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017 Dec 12;61(6):585–596.
   PubMed Web of Science ®Google Scholar
• Zuleger T, Heinzelbecker J, Takacs Z, et al. SGK1 inhibits autophagy in murine muscle tissue. Oxid Med Cell Longev. 2018;2018:4043726.
   PubMed Web of Science ®Google Scholar
• Conza D, Mirra P, Cali G, et al. The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells. J Cell Physiol. 2017 Dec;232(12):3735–3743.
   PubMed Web of Science ®Google Scholar
• Webster MK, Goya L, Firestone GL. Immediate-early transcriptional regulation and rapid mRNA turnover of a putative serine/threonine protein kinase. J Biol Chem. 1993 Jun 5;268(16):11482–11485.
   PubMed Web of Science ®Google Scholar
• Webster MK, Goya L, Ge Y, et al. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol. 1993 Apr;13(4):2031–2040.
   PubMed Web of Science ®Google Scholar
• Waldegger S, Barth P, Raber G, et al. Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4440–4445.
   PubMed Web of Science ®Google Scholar
• Hinds LR, Chun LE, Woodruff ER, et al. Dynamic glucocorticoid-dependent regulation of Sgk1 expression in oligodendrocytes of adult male rat brain by acute stress and time of day. PLoS One. 2017;12(4):e0175075.
   PubMed Web of Science ®Google Scholar
• Rauz S, Walker EA, Murray PI, et al. Expression and distribution of the serum and glucocorticoid regulated kinase and the epithelial sodium channel subunits in the human cornea. Exp Eye Res. 2003 Jul;77(1):101–108.
   PubMed Web of Science ®Google Scholar
• Cordas E, Naray-Fejes-Toth A, Fejes-Toth G. Subcellular location of serum- and glucocorticoid-induced kinase-1 in renal and mammary epithelial cells. Am J Physiol Cell Physiol. 2007 May;292(5):C1971–81.
   PubMed Web of Science ®Google Scholar
• Klingel K, Warntges S, Bock J, et al. Expression of cell volume-regulated kinase h-sgk in pancreatic tissue. Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G998–G1002.
   PubMed Web of Science ®Google Scholar
• Lang F, Artunc F, Vallon V. The physiological impact of the serum and glucocorticoid-inducible kinase SGK1. Curr Opin Nephrol Hypertens. 2009 Sep;18(5):439–448.
   PubMed Web of Science ®Google Scholar
• Engelsberg A, Kobelt F, Kuhl D. The N-terminus of the serum- and glucocorticoid-inducible kinase Sgk1 specifies mitochondrial localization and rapid turnover. Biochem J. 2006 Oct 1;399(1):69–76.
   PubMedGoogle Scholar
• Bogusz AM, Brickley DR, Pew T, et al. A novel N-terminal hydrophobic motif mediates constitutive degradation of serum- and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway. Febs J. 2006 Jul;273(13):2913–2928.
   PubMed Web of Science ®Google Scholar
• Lang F, Stournaras C, Zacharopoulou N, et al. Serum- and glucocorticoid-inducible kinase 1 and the response to cell stress. Cell Stress. 2018 Dec 2;3(1):1–8.
   PubMedGoogle Scholar
• Leong ML, Maiyar AC, Kim B, et al. Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem. 2003 Feb 21;278(8):5871–5882.
   PubMed Web of Science ®Google Scholar
• Uniprot. Serine/threonine-protein kinase Sgk1 2019. Available from: https://www.uniprot.org/uniprot/O00141
   Google Scholar
• Zhao B, Lehr R, Smallwood AM, et al. Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP. Protein Sci. 2007 Dec;16(12):2761–2769.
   PubMed Web of Science ®Google Scholar
• Hammond M, Washburn DG, Hoang HT, et al. Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4441–4445.
   PubMed Web of Science ®Google Scholar
• Arencibia JM, Pastor-Flores D, Bauer AF, et al. AGC protein kinases: from structural mechanism of regulation to allosteric drug development for the treatment of human diseases. Biochim Biophys Acta. 2013 Jul;1834(7):1302–1321.
   PubMed Web of Science ®Google Scholar
• Garcia-Martinez JM, Alessi DR. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J. 2008 Dec 15;416(3):375–385.
   PubMed Web of Science ®Google Scholar
• Lang F, Cohen P. Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms. Sci STKE. 2001 Nov 13;2001(108):re17.
   PubMedGoogle Scholar
• Kobayashi T, Deak M, Morrice N, et al. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase. Biochem J. 1999 Nov 15;344(Pt 1):189–197.
   PubMed Web of Science ®Google Scholar
• Loffing J, Flores SY, Staub O. Sgk kinases and their role in epithelial transport. Annu Rev Physiol. 2006;68:461–490.
   PubMed Web of Science ®Google Scholar
• Bago R, Malik N, Munson MJ, et al. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase. Biochem J. 2014 Nov 1;463(3):413–427.
   PubMed Web of Science ®Google Scholar
• Lang F, Bohmer C, Palmada M, et al. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev. 2006 Oct;86(4):1151–1178.
   PubMed Web of Science ®Google Scholar
• McCormick JA, Feng Y, Dawson K, et al. Targeted disruption of the protein kinase SGK3/CISK impairs postnatal hair follicle development. Mol Biol Cell. 2004 Sep;15(9):4278–4288.
   PubMed Web of Science ®Google Scholar
• Pao AC, McCormick JA, Li H, et al. NH2 terminus of serum and glucocorticoid-regulated kinase 1 binds to phosphoinositides and is essential for isoform-specific physiological functions. Am J Physiol Renal Physiol. 2007 Jun;292(6):F1741–50.
   PubMed Web of Science ®Google Scholar
• Raikwar NS, Snyder PM, Thomas CP. An evolutionarily conserved N-terminal Sgk1 variant with enhanced stability and improved function. Am J Physiol Renal Physiol. 2008 Nov;295(5):F1440–8.
   PubMed Web of Science ®Google Scholar
• Arteaga MF, Coric T, Straub C, et al. A brain-specific SGK1 splice isoform regulates expression of ASIC1 in neurons. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4459–4464.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Fernandez R, Avila J, Arteaga MF, et al. The neuronal-specific SGK1.1 (SGK1_v2) kinase as a transcriptional modulator of BAG4, brox, and PPP1CB genes expression. Int J Mol Sci. 2015 Apr 2;16(4):7462–7477.
   PubMed Web of Science ®Google Scholar
• Wemmie JA, Taugher RJ, Kreple CJ. Acid-sensing ion channels in pain and disease. Nat Rev Neurosci. 2013 Jul;14(7):461–471.
   PubMed Web of Science ®Google Scholar
• Bhalla V, Soundararajan R, Pao AC, et al. Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ. Am J Physiol Renal Physiol. 2006 Oct;291(4):F714–21.
   PubMed Web of Science ®Google Scholar
• Debonneville C, Flores SY, Kamynina E, et al. Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na(+) channel cell surface expression. Embo J. 2001 Dec 17;20(24):7052–7059.
   PubMed Web of Science ®Google Scholar
• Diakov A, Korbmacher C. A novel pathway of epithelial sodium channel activation involves a serum- and glucocorticoid-inducible kinase consensus motif in the C terminus of the channel’s alpha-subunit. J Biol Chem. 2004 Sep 10;279(37):38134–38142.
   PubMed Web of Science ®Google Scholar
• Palmada M, Embark HM, Wyatt AW, et al. Negative charge at the consensus sequence for the serum- and glucocorticoid-inducible kinase, SGK1, determines pH sensitivity of the renal outer medullary K+ channel, ROMK1. Biochem Biophys Res Commun. 2003 Aug 8;307(4):967–972.
   PubMed Web of Science ®Google Scholar
• Sandulache D, Grahammer F, Artunc F, et al. Renal Ca2+ handling in sgk1 knockout mice. Pflugers Arch. 2006 Jul;452(4):444–452.
   PubMed Web of Science ®Google Scholar
• Chun J, Kwon T, Kim DJ, et al. Inhibition of mitogen-activated kinase kinase kinase 3 activity through phosphorylation by the serum- and glucocorticoid-induced kinase 1. J Biochem. 2003 Jan;133(1):103–108.
   PubMed Web of Science ®Google Scholar
• Sakoda H, Gotoh Y, Katagiri H, et al. Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem. 2003 Jul 11;278(28):25802–25807.
   PubMed Web of Science ®Google Scholar
• Jeyaraj S, Boehmer C, Lang F, et al. Role of SGK1 kinase in regulating glucose transport via glucose transporter GLUT4. Biochem Biophys Res Commun. 2007 May 11;356(3):629–635.
   PubMed Web of Science ®Google Scholar
• Boini KM, Hennige AM, Huang DY, et al. Serum- and glucocorticoid-inducible kinase 1 mediates salt sensitivity of glucose tolerance. Diabetes. 2006 Jul;55(7):2059–2066.
   PubMed Web of Science ®Google Scholar
• Martin-Fernandez B, Valero Munoz M, de Las Heras N, et al. Relevance of SGK1 in structural, functional and molecular alterations produced by aldosterone in heart. Horm Mol Biol Clin Investig. 2014 May;18(2):53–61.
   PubMedGoogle Scholar
• Lamothe SM, Zhang S. The serum- and glucocorticoid-inducible kinases SGK1 and SGK3 regulate hERG channel expression via ubiquitin ligase Nedd4-2 and GTPase Rab11. J Biol Chem. 2013 May 24;288(21):15075–15084.
   PubMed Web of Science ®Google Scholar
• Murray JT, Campbell DG, Morrice N, et al. Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochem J. 2004 Dec 15;384(Pt 3):477–488.
   PubMedGoogle Scholar
• Sahin P, McCaig C, Jeevahan J, et al. The cell survival kinase SGK1 and its targets FOXO3a and NDRG1 in aged human brain. Neuropathol Appl Neurobiol. 2013 Oct;39(6):623–633.
   PubMed Web of Science ®Google Scholar
• Wu C, Yosef N, Thalhamer T, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature. 2013 Apr 25;496(7446):513–517.
   PubMed Web of Science ®Google Scholar
• Hernandez AL, Kitz A, Wu C, et al. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J Clin Invest. 2015 Nov 2;125(11):4212–4222.
   PubMed Web of Science ®Google Scholar
• Wu C, Chen Z, Xiao S, et al. SGK1 governs the reciprocal development of th17 and regulatory t cells. Cell Rep. 2018 Jan 16;22(3):653–665.
   PubMed Web of Science ®Google Scholar
• Abbruzzese C, Mattarocci S, Pizzuti L, et al. Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas. J Exp Clin Cancer Res. 2012 Jan 12;31:4.
   PubMed Web of Science ®Google Scholar
• Talarico C, Dattilo V, D’Antona L, et al. SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. Oncotarget. 2016 Mar 29;7(13):15868–15884.
   PubMedGoogle Scholar
• Chung EJ, Sung YK, Farooq M, et al. Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol Cells. 2002 Dec 31;14(3):382–387.
   PubMed Web of Science ®Google Scholar
• Liang X, Lan C, Jiao G, et al. Therapeutic inhibition of SGK1 suppresses colorectal cancer. Exp Mol Med. 2017 Nov 24;49(11):e399.
   PubMedGoogle Scholar
• Sommer EM, Dry H, Cross D, et al. Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors. Biochem J. 2013 Jun 15;452(3):499–508.
   PubMedGoogle Scholar
• Artunc F, Lang F. Mineralocorticoid and SGK1-sensitive inflammation and tissue fibrosis. Nephron Physiol. 2014;128(1–2):35–39.
   PubMedGoogle Scholar
• Zhang L, Cui R, Cheng X, et al. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase. Cancer Res. 2005 Jan 15;65(2):457–464.
   PubMed Web of Science ®Google Scholar
• Lang F, Stournaras C. Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth. Hormones (Athens). 2013 Apr;12(2):160–171.
   PubMedGoogle Scholar
• Waldegger S, Klingel K, Barth P, et al. h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology. 1999 May;116(5):1081–1088.
   PubMed Web of Science ®Google Scholar
• Yang M, Zheng J, Miao Y, et al. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1675–1686.
   PubMed Web of Science ®Google Scholar
• Du YN, Tang XF, Xu L, et al. SGK1-FoxO1 signaling pathway mediates th17/treg imbalance and target organ inflammation in angiotensin ii-induced hypertension. Front Physiol. 2018;9:1581.
   PubMed Web of Science ®Google Scholar
• Spagnuolo R, Dattilo V, D’Antona L, et al. Deregulation of SGK1 in ulcerative colitis: a paradoxical relationship between immune cells and colonic epithelial cells. Inflamm Bowel Dis. 2018 May 18;24:1967–1977.
   PubMed Web of Science ®Google Scholar
• Nishida Y, Nagata T, Takahashi Y, et al. Alteration of serum/glucocorticoid regulated kinase-1 (sgk-1) gene expression in rat hippocampus after transient global ischemia. Brain Res Mol Brain Res. 2004 Apr 7;123(1–2):121–125.
   PubMedGoogle Scholar
• Rusai K, Wagner B, Roos M, et al. The serum and glucocorticoid-regulated kinase 1 in hypoxic renal injury. Cell Physiol Biochem. 2009;24(5–6):577–584.
   PubMedGoogle Scholar
• Busjahn A, Aydin A, Uhlmann R, et al. Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure. Hypertension. 2002 Sep;40(3):256–260.
   PubMed Web of Science ®Google Scholar
• Bubien JK. Epithelial Na+ channel (ENaC), hormones, and hypertension. J Biol Chem. 2010 Jul 30;285(31):23527–23531.
   PubMed Web of Science ®Google Scholar
• von Wowern F, Berglund G, Carlson J, et al. Genetic variance of SGK-1 is associated with blood pressure, blood pressure change over time and strength of the insulin-diastolic blood pressure relationship. Kidney Int. 2005 Nov;68(5):2164–2172.
   PubMed Web of Science ®Google Scholar
• Voelkl J, Lin Y, Alesutan I, et al. Sgk1 sensitivity of Na(+)/H(+) exchanger activity and cardiac remodeling following pressure overload. Basic Res Cardiol. 2012 Mar;107(2):236.
   PubMed Web of Science ®Google Scholar
• Zarrinpashneh E, Poggioli T, Sarathchandra P, et al. Ablation of SGK1 impairs endothelial cell migration and tube formation leading to decreased neo-angiogenesis following myocardial infarction. PLoS One. 2013;8(11):e80268.
   PubMed Web of Science ®Google Scholar
• Bezzerides VJ, Zhang A, Xiao L, et al. Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders. Sci Rep. 2017 Mar 23;7(1):346.
   PubMedGoogle Scholar
• Voelkl J, Luong TT, Tuffaha R, et al. SGK1 induces vascular smooth muscle cell calcification through NF-kappaB signaling. J Clin Invest. 2018 Jul 2;128(7):3024–3040.
   PubMed Web of Science ®Google Scholar
• Borst O, Schaub M, Walker B, et al. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis. Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):547–557.
   PubMed Web of Science ®Google Scholar
• Xi X, Zhang J, Wang J, et al. SGK1 mediates hypoxic pulmonary hypertension through promoting macrophage infiltration and activation. Anal Cell Pathol (Amst). 2019;2019:3013765.
   PubMedGoogle Scholar
• Schwab M, Lupescu A, Mota M, et al. Association of SGK1 gene polymorphisms with type 2 diabetes. Cell Physiol Biochem. 2008;21(1–3):151–160.
   PubMedGoogle Scholar
• Zhuang L, Jin G, Hu X, et al. The inhibition of SGK1 suppresses epithelial-mesenchymal transition and promotes renal tubular epithelial cell autophagy in diabetic nephropathy. Am J Transl Res. 2019;11(8):4946–4956.
   PubMed Web of Science ®Google Scholar
• Ganesh S, Puri R, Singh S, et al. Recent advances in the molecular basis of Lafora’s progressive myoclonus epilepsy. J Hum Genet. 2006;51(1):1–8.
   PubMed Web of Science ®Google Scholar
• Serratosa JM, Minassian BA, Ganesh S. Progressive myoclonus epilepsy of Lafora. In: Noebels JL, Avoli M, et al., editors. Jasper’s Basic Mechanisms of the Epilepsies 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.
   Google Scholar
• Singh PK, Singh S, Ganesh S. The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters. Mol Cell Biol. 2012 Feb;32(3):652–663.
   PubMed Web of Science ®Google Scholar
• Singh S, Ganesh S. Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes. Hum Mutat. 2009 May;30(5):715–723.
   PubMed Web of Science ®Google Scholar
• Singh PK, Singh S, Ganesh S. Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease. Mol Biol Cell. 2013 Dec;24(24):3776–3786.
   PubMed Web of Science ®Google Scholar
• Sato H, Horikawa Y, Iizuka K, et al. Large-scale analysis of glucocorticoid target genes in rat hypothalamus. J Neurochem. 2008 Jul;106(2):805–814.
   PubMed Web of Science ®Google Scholar
• Sheng H, Sun T, Cong B, et al. Corticotropin-releasing hormone stimulates SGK-1 kinase expression in cultured hippocampal neurons via CRH-R1. Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E938–46.
   PubMed Web of Science ®Google Scholar
• Huguet G, Aldavert-Vera L, Kadar E, et al. Intracranial self-stimulation to the lateral hypothalamus, a memory improving treatment, results in hippocampal changes in gene expression. Neuroscience. 2009 Aug 18;162(2):359–374.
   PubMed Web of Science ®Google Scholar
• Lang F, Strutz-Seebohm N, Seebohm G, et al. Significance of SGK1 in the regulation of neuronal function. J Physiol. 2010 Sep 15;588(Pt 18):3349–3354.
   PubMed Web of Science ®Google Scholar
• Chun J, Kwon T, Lee EJ, et al. 14-3-3 Protein mediates phosphorylation of microtubule-associated protein tau by serum- and glucocorticoid-induced protein kinase 1. Mol Cells. 2004 Dec 31;18(3):360–368.
   PubMed Web of Science ®Google Scholar
• Gaertner RF, Wyss-Coray T, Von Euw D, et al. Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing alzheimer’s disease-like cerebrovascular abnormalities. Neurobiol Dis. 2005 Jun;19(1–2):38–46.
   PubMed Web of Science ®Google Scholar
• Schoenebeck B, Bader V, Zhu XR, et al. Sgk1, a cell survival response in neurodegenerative diseases. Mol Cell Neurosci. 2005 Oct;30(2):249–264.
   PubMed Web of Science ®Google Scholar
• Stichel CC, Schoenebeck B, Foguet M, et al. sgk1, a member of an RNA cluster associated with cell death in a model of parkinson’s disease. Eur J Neurosci. 2005 Jan;21(2):301–316.
   PubMed Web of Science ®Google Scholar
• Iwata S, Nomoto M, Morioka H, et al. Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice. Synapse. 2004 Mar 15;51(4):279–286.
   PubMed Web of Science ®Google Scholar
• Iqbal S, Howard S, LoGrasso PV. Serum- and glucocorticoid-inducible kinase 1 confers protection in cell-based and in in vivo neurotoxin models via the c-Jun n-Terminal kinase signaling pathway. Mol Cell Biol. 2015 Jun 1;35(11):1992–2006.
   PubMed Web of Science ®Google Scholar
• Rangone H, Poizat G, Troncoso J, et al. The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. Eur J Neurosci. 2004 Jan;19(2):273–279.
   PubMed Web of Science ®Google Scholar
• Korn T, Reddy J, Gao W, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med. 2007 Apr;13(4):423–431.
   PubMed Web of Science ®Google Scholar
• Das S, Aiba T, Rosenberg M, et al. Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation. 2012 Oct 30;126(18):2208–2219.
   PubMed Web of Science ®Google Scholar
• Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Investig Drugs. 2013 Jun;22(6):701–714.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011 Feb;13(2):132–141.
   PubMed Web of Science ®Google Scholar
• Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013 Feb 14;368(7):651–662.
   PubMed Web of Science ®Google Scholar
• Kim LC, Cook RS, Chen J. mTORC1 and mTORC2 in cancer and the tumor microenvironment. Oncogene. 2017 Apr 20;36(16):2191–2201.
   PubMed Web of Science ®Google Scholar
• Lu M, Wang J, Jones KT, et al. mTOR complex-2 activates ENaC by phosphorylating SGK1. J Am Soc Nephrol. 2010 May;21(5):811–818.
   PubMed Web of Science ®Google Scholar
• Aspernig H, Heimbucher T, Qi W, et al. Mitochondrial perturbations couple mTORC2 to autophagy in C.elegans. Cell Rep. 2019 Nov 5;29(6):1399–1409 e5.
   PubMed Web of Science ®Google Scholar
• Bain J, Plater L, Elliott M, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007 Dec 15;408(3):297–315.
   PubMed Web of Science ®Google Scholar
• Sherk AB, Frigo DE, Schnackenberg CG, et al. Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic. Cancer Res. 2008 Sep 15;68(18):7475–7483.
   PubMed Web of Science ®Google Scholar
• MRC PPU International Center for Kinase Profiling. Kinase profiling inhibitor database: GSK650394A. Available from: http://www.kinase-screen.mrc.ac.uk/screening-compounds/348807
   Google Scholar
• Liu W, Wang X, Liu Z, et al. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway. Br J Cancer. 2017 Oct 10;117(8):1139–1153.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang X, Wang Y, et al. SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT. J Exp Clin Cancer Res. 2018 Apr 2;37(1):73.
   PubMedGoogle Scholar
• Inoue K, Leng T, Yang T, et al. Role of serum- and glucocorticoid-inducible kinases in stroke. J Neurochem. 2016 Jul;138(2):354–361.
   PubMed Web of Science ®Google Scholar
• Anacker C, Cattaneo A, Musaelyan K, et al. Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc Natl Acad Sci U S A. 2013 May 21;110(21):8708–8713.
   PubMed Web of Science ®Google Scholar
• Liang X, Lan C, Zhou J, et al. Development of a new analog of SGK1 inhibitor and its evaluation as a therapeutic molecule of colorectal cancer. J Cancer. 2017;8(12):2256–2262.
   PubMed Web of Science ®Google Scholar
• Ackermann TF, Boini KM, Beier N, et al. EMD638683, a novel SGK inhibitor with antihypertensive potency. Cell Physiol Biochem. 2011;28(1):137–146.
   PubMedGoogle Scholar
• Gan W, Ren J, Li T, et al. The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation. Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):1–10.
   PubMed Web of Science ®Google Scholar
• Xi X, Liu S, Shi H, et al. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension. Cardiovasc Toxicol. 2014 Dec;14(4):368–378.
   PubMed Web of Science ®Google Scholar
• Li P, Hao Y, Pan FH, et al. SGK1 inhibitor reverses hyperglycemia partly through decreasing glucose absorption. J Mol Endocrinol. 2016 May;56(4):301–309.
   PubMed Web of Science ®Google Scholar
• Halland N, Schmidt F, Weiss T, et al. Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as highly active and selective SGK1 inhibitors. ACS Med Chem Lett. 2015 Jan 8;6(1):73–78.
   PubMed Web of Science ®Google Scholar
• Schoene J, Gazzi T, Lindemann P, et al. Probing 2H-indazoles as templates for SGK1, Tie2, and SRC kinase inhibitors. ChemMedChem. 2019 Aug 20;14(16):1514–1527.
   PubMed Web of Science ®Google Scholar
• Geldenhuys WJ, Talasila PK, Sadana P. Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening. Bioorg Med Chem Lett. 2012 Sep 1;22(17):5675–5678.
   PubMed Web of Science ®Google Scholar
• D’Antona L, Amato R, Talarico C, et al. SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation. Cell Physiol Biochem. 2015;35(5):2006–2018.
   PubMedGoogle Scholar
• Catalogna G, Talarico C, Dattilo V, et al. The SGK1 kinase inhibitor SI113 sensitizes theranostic effects of the 64CuCl2 in human glioblastoma multiforme cells. Cell Physiol Biochem. 2017;43(1):108–119.
   PubMedGoogle Scholar
• Matteoni S, Abbruzzese C, Matarrese P, et al. The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells. J Exp Clin Cancer Res. 2019 May 17;38(1):202.
   PubMedGoogle Scholar
• Akhoon BA, Gandhi NS, Pandey R. Computational insights into the active structure of SGK1 and its implication for ligand design. Biochimie. 2019 Oct;165:57–66.
   PubMed Web of Science ®Google Scholar